humanitarian

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation: 20/08/2026, Revision: 1, Status: Authorised

Reported by EMA What Is New Oct 14, 2026 · 14:45 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised14:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised14:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 33, Status: Authorised14:34 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 33, Status: Authorised14:34 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised14:14 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised14:14 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/…14:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/…14:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised13:50 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised13:50 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 14, Status: Authorised13:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 14, Status: Authorised13:38 UTC

INCIDENT EVOLUTION

3 recorded states

Oct 14 · 15:07 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 14 · 15:12 UTC

Headline updatedP2 · 99% quality · 2 sources

Oct 14 · 15:57 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →